Methacrylic Acid

Methacrylic Acid

SCHEMBL4910474

C=C(C)C(=O)O.Oc1ccnc(-c2ccccn2)c1O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.41
KDM6B O15054 1/20 0.41
KDM4A O75164 1/20 0.41
KDM5C P41229 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
KDM2A Q9Y2K7 1/20 0.41
KDM3A Q9Y4C1 1/20 0.41
ALDH1A1 P00352 5/20 0.38
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CCR1 P32246 1/20 0.36
CCR5 P51681 1/20 0.36
CCR8 P51685 1/20 0.36
METAP1 P53582 1/20 0.36
BLM P54132 1/20 0.36
HIF1A Q16665 1/20 0.36
DOHH Q9BU89 1/20 0.36
P4HTM Q9NXG6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3981999 0.84 KDM4E (0.50) KDM4EKDM6BKDM4AKDM5CKDM4C
Dipyridyl SCHEMBL4954412 0.81 KDM4E (0.56) KDM4EKDM6BKDM4AKDM5CKDM4C
SCHEMBL28453174 0.72 KDM4E (0.49) KDM4EKDM6BKDM4AKDM5CKDM4C
SCHEMBL28449259 0.72 KDM4E (0.53) KDM4EALDH1A1NPC1LMNACYP1A2
SCHEMBL4657861 0.71 KDM4E (0.50) KDM4EKDM6BKDM4AKDM5CKDM4C
SCHEMBL8546751 0.71 KDM4E (0.42) KDM4EALDH1A1NPC1LMNACYP1A2
Dipyridyl SCHEMBL4881410 0.70 KDM4E (0.67) KDM4EKDM6BKDM4AKDM5CKDM4C
Dipyridyl SCHEMBL9641711 0.70 KDM4E (0.67) KDM4EKDM6BKDM4AKDM5CKDM4C
Dipyridyl SCHEMBL11231947 0.70 KDM4E (0.67) KDM4EKDM6BKDM4AKDM5CKDM4C
SCHEMBL3143645 0.70 KDM4E (0.49) KDM4EKDM6BKDM4AKDM5CKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058579-A1 Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors ANGIOTECH INTERNATIONAL AG (CH) 2008-03-06 US disclosed
US-20030144570-A1 Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors ANGIOTECH PHARMACEUTICALS, INC. (CA) 2003-07-31 US disclosed
US-20020055666-A1 Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors ANGIOTECH INTERNATIONAL AG (CH) 2002-05-09 US disclosed